Jiahua He - Publications

Corrigendum to: Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis: Cancer Treatment and Research Communications 46 (2026) 101059.

Journal: Cancer treatment and research communications

Published: January 15, 2026

Feedback regulation between histone H3 lysine 18 lactylation and TROP2-mediated glycolysis drives metastatic progression of colorectal cancer.

Journal: Clinical and translational medicine

Published: August 18, 2025

PKM2 Lactylation Promotes Colorectal Cancer Vasculogenic Mimicry and Bevacizumab Resistance by Facilitating FOSL1 Super-enhancer Formation.

Journal: Cancer research

Published: August 07, 2025

Impact of TGF-β1 on tumor immune microenvironment and prognosis in colorectal liver oligometastasis.

Journal: Cancer treatment and research communications

Published: July 01, 2025

Prognostic significance of DNA ploidy, stroma fraction, and nucleotyping in stage IIIb colon cancer and their implications for adjuvant chemotherapy.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: June 25, 2025

β-elemene promotes ferroptosis to improve the sensitivity of imatinib in gastrointestinal stromal tumours by targeting N6AMT1.

Journal: Clinical and translational medicine

Published: April 13, 2025

Cancer associated fibroblasts-derived lactate induces oxaliplatin treatment resistance by promoting cancer stemness via ANTXR1 lactylation in colorectal cancer.

Journal: Cancer letters

Published: March 21, 2025

Chromosomal instability is associated with prognosis and efficacy of bevacizumab after resection of colorectal cancer liver metastasis.

Journal: Annals of medicine

Published: September 09, 2024

MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastases.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: July 08, 2024

Combination of DNA ploidy, stroma, and nucleotyping predicting prognosis and tailoring adjuvant chemotherapy duration in stage III colon cancer.

Journal: Therapeutic advances in medical oncology

Published: February 07, 2024

Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer.

Journal: Autophagy

Published: August 24, 2023

Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases.

Journal: BMC surgery

Published: February 13, 2023